Ventricular Cardiac Organoid

  • Ventricular Cardiac Organoid

Human iPSC-derived Ventricular Cardiac Organoid

These organoids are generated from human iPSCs to model the structural and functional characteristics of ventricular myocardium in a 3D format. They exhibit synchronized contractions, robust ventricular-like electrophysiology, and chamber-specific gene expression, making them powerful systems for disease modeling, drug testing, and safety pharmacology.

Benefits

  • 3D organoid structure mimicking ventricular tissue architecture
  • Chamber-specific electrophysiological and contractile properties
  • Useful for cardiac safety pharmacology and disease modeling

Product Specifications

Feature

Detail

Identity Markers

High expression of ventricular markers (MLC2v, TNNT2, α-actinin); downregulation of pluripotency markers

Quantities

≥ 1 × 10⁶ cells per organoid; batch sizes available

Quality Control

Electrophysiological assays (Voltage/Calcium probes), contractility assays, mycoplasma testing

Format

Cryopreserved 3D organoids

Donor & Reprogramming

Healthy or disease-specific donor; Sendai virus reprogramming

Shipping / Storage

Dry shipper at -180°C to -135°C; store in vapor phase LN₂

Supplied with

Organoid culture medium and user-guide

Explore Ventricular Cardiac Organoid

Discover our high-purity, iPSC-derived ventricular cardiomyocytes designed for cardiac safety, electrophysiology, and drug discovery research. Check out the product details to see how these cells can accelerate your studies.

Our Products